glp-1 drugs and muscle loss loss: what's the real story? | Stuart Phillips posted on the topic GLP-1 Drugs & What They

What makes BPC-157 different from growth peptides

Typically, patients either start the GLP-1 medication first and add BPC-157 during titration, or begin BPC-157 proactively before starting GLP-1 therapy

A typical pediatric dose is approximately 0.03 mg per kilogram of body weight (30 g/kg) once daily at bedtime

This was more pronounced in trials for early-stage cancers, with protocol exclusion criteria on the basis of organ-system abnormalities and functional status limitations being associated with lower elderly participation (the authors estimate that relaxing those eligibility restrictions would increase their share to 60 percent) (Lewis et al., 2003)

Once in the brain, glucose is metabolized to pyruvate, which enters the mitochondria of the brain cells to generate energy through aerobic metabolism